MGC Pharma ASX MXC CannEpil UK epilepsy distribution

MGC Pharma officially enters UK with CannEpil distribution to begin immediately

Medicinal cannabis producer MGC Pharmaceuticals’ (ASX: MXC) first CannEpil shipment to the UK has landed on British soil and will be immediately distributed to...
MGC Pharmaceuticals ASX MXC nutraceuticals CBD Chinese health products YuShop Global

MGC Pharmaceuticals enters Chinese market with CBD products

Biopharmaceutical company MGC Pharmaceuticals (ASX: MXC) is entering the Chinese health market, inking a deal with e-commerce import platform YuShop Global to sell its...
MGC Pharmaceuticals ASX MXC TGA approval CannEpil medicinal cannabis product Australia

MGC Pharmaceuticals receives TGA approval to market its CannEpil medicinal cannabis product in Australia

Aspiring bio-pharmaceutical company MGC Pharmaceuticals (ASX: MXC) has received formal authorisation to supply its CannEpil product through specialist prescribers under the ‘Authorised Prescriber Scheme’...
MGC Pharmaceuticals ASX MXC cannabis potential treatment fight against dementia

MGC Pharmaceuticals positions cannabis as a potential treatment in the fight against dementia

Biopharma developer MGC Pharmaceuticals (ASX: MXC) plans to apply the potential benefits of cannabis to mitigate the impact of dementia. Earlier this morning, the company...
Harvey Nichols UK MGC Pharmaceuticals ASX MXC CBD Derma range cannabidiol

UK’s Harvey Nichols to expand MGC Pharmaceuticals CBD Derma range

MGC Pharmaceuticals (ASX: MXC) has received strong commercial news this morning with the news that UK-based retailer Harvey Nichols has decided to expand the...
MGC Pharmaceuticals ASX MXC GMP certificate manufacturing licence CannEpil

MGC Pharmaceuticals receives key medical cannabis certification and manufacturing licence

Biopharma company MGC Pharmaceuticals (ASX: MXC) has received its GMP certification and formal manufacturing licence to produce Good Manufacturing Practice (GMP) grade medical cannabis...
Malta medical cannabis legislation ASX MGC Pharmaceuticals MXC

MGC Pharmaceuticals celebrates medical cannabis legislative change in Malta

The final piece of its cannabis production line has now slotted into place for MGC Pharmaceuticals (ASX: MXC) after final legislation was passed by...
MGC Pharmaceutics ASX MGC CBD Herbal Replenish cream launched

MGC Pharmaceuticals launches latest cannabidiol skincare product

Medicinal cannabis and its expansive set of applications continue to encroach upon commercial markets with MGC Pharmaceuticals (ASX: MXC) launching yet another cannabidiol-based product...
MGC Pharma ASX MXC medical cannabis facility Malta

MGC Pharma gets go-ahead to build medical cannabis facility in Malta, tops up cash

MGC Pharma (ASX: MXC) has grown its medical cannabis production capabilities after the Maltese Government gave the company the go-ahead to construct and operate...
MGC Pharmaceuticals ASX MXC CannEpil production

MGC Pharmaceuticals commences production of CannEpil product for epilepsy

Medicinal cannabis is emerging into mainstream consumption, one approval at a time for MGC Pharmaceuticals (ASX: MXC). As one of the world’s most avant-garde market...
MGC Derma Pharma ASX MXC Cult Beauty

MGC Pharma’s cannabidiol cosmetics launch on Cult Beauty online store

Australian medicinal cannabis company MGC Pharmaceuticals (ASX: MXC) has officially launched its range of MGC Derma and Derma Plus cannabidiol (CBD) cosmetic and skin...
MGC Pharmaceuticals ASX MXC CannEpil medicinal cannabis Europe Good Manufacturing Practice

MGC Pharma granted green light to start manufacturing CannEpil for distribution

MGC Pharmaceuticals (ASX: MXC) has been given the greenlight to begin manufacturing its medicinal cannabis-based products at its European production facility, after receiving interim...